Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Treatment choice after EGFR-TKI resistance].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Oct 2013

Li Junling

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Neoplasms
Share to Mutation
Share to Protein Kinase Inhibitors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Share to Drug Resistance, Neoplasm

Share to ErbB Receptors

Source

Open in PubMed Open full text

Identifiers

PMID: 24113001
DOI: 10.3779/j.issn.1009-3419.2013.10.01
PMCID: PMC6015177

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Treatment choice after EGFR-TKI resistance].PMID 24113001Read ↗

Treatment choice in EGFR-mutant non-small-cell lung cancer.Semantic proximity Read ↗

[I. What is the Standard Treatment of EGFR-TKIs? Did EGFR-TKIs Improve Treatment for Non-Small Cell Lung Cancer?].Semantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

Optimising therapy for EGFR-addicted NSCLC: just the start.Semantic proximity Read ↗

[Personalized medicine in non-small-cell carcinoma].Semantic proximity Read ↗

[Features of developing resistance during combined use of antineoplastic agents, causing multiple drug resistance].Semantic proximity Read ↗

[Acquired resistance mechanisms to EGFR-TKIs in EGFR mutated lung cancers].Semantic proximity Read ↗

[BRAF inhibitor and MEK inhibitor].Semantic proximity Read ↗

[From ASCO and WCLC 2005 to the clinical practice: targeted therapies].Semantic proximity Read ↗

Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-Tyrosine Kinase Inhibitors: A Retrospective Dual-Center StudySemantic proximity Read ↗

[Oncology 2010].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.